Resibufogenin suppresses tumor growth and inhibits glycolysis in ovarian cancer by modulating PIM1
- Type
- Retraction
- Notice date
- 11/26/2020 0:00
- Journal
- Naunyn-Schmiedeberg's Archives of Pharmacology
- Publisher
- Springer
- Notice DOI
- 10.1007/s00210-020-02016-8
- Original paper DOI
- 10.1007/s00210-019-01687-2